Cargando…
Mortality following development of breast cancer while using oestrogen or oestrogen plus progestin: a computer record-linkage study
The literature on the relationship between breast cancer mortality and postmenopausal oestrogen and combined oestrogen/progestin therapy is seemingly contradictory. This study explored survival after exposure to oestrogen or oestrogen plus progestin at or in the year prior to breast cancer diagnosis...
Autores principales: | Chen, W, Petitti, D B, Geiger, A M |
---|---|
Formato: | Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group
2005
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2361586/ https://www.ncbi.nlm.nih.gov/pubmed/16106246 http://dx.doi.org/10.1038/sj.bjc.6602701 |
Ejemplares similares
-
An overview of menopausal oestrogen–progestin hormone therapy and breast cancer risk
por: Lee, S A, et al.
Publicado: (2005) -
Plasma oestrogens and oestrogen receptors in breast cancer patients.
por: Mason, R. C., et al.
Publicado: (1985) -
Low‐dose oestrogen–progestin associated pulmonary infarction mimicking pneumonia and pleurisy
por: Gocho, Kyoko, et al.
Publicado: (2021) -
CITED2 and NCOR2 in anti-oestrogen resistance and progression of breast cancer
por: van Agthoven, T, et al.
Publicado: (2009) -
Oestrogens and oestrogen receptors in prostate cancer
por: Kowalska, Karolina, et al.
Publicado: (2016)